Why the study?
Does augmenting standard antidepressant therapy with nimodipine improve depression reduction and prevent recurrence in patients with vascular depression?
Does augmenting standard antidepressant therapy with nimodipine improve depression reduction and prevent recurrence in patients with vascular depression?
Augmenting standard antidepressant therapy with nimodipine in patients with vascular depression leads to greater depression reduction and lower rates of recurrence.
No takes yet. Share an insight, caveat, or question.
Supports nimodipine augmentation of antidepressants in vascular depression; confirms efficacy in this RCT.
Taragano et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: